MODIFIED PHENYLPHTHALIMIDE AND PHARMACEUTICAL COMPOSITION HAVING SAME AS ACTIVE INGREDIENT
申请人:Keio University
公开号:EP3530652A1
公开(公告)日:2019-08-28
A phenylphthalimide derivative represented by the following general formula is provided as a phenylphthalimide derivative useful against various cancers including multiple myeloma,
wherein R1 is a group containing PEG or a hydroxy C1-5 alkoxy group binding to position 4 or position 5, R2 is an amino group at position 6, and R3 and R4 are each independently a hydrogen atom, an alkyl group, an aryl group, an aralkyl group, or an aryloxy group.
由以下通式代表的苯基邻苯二甲酰亚胺衍生物可作为一种苯基邻苯二甲酰亚胺衍生物用于抗击包括多发性骨髓瘤在内的各种癌症、
其中,R1 是含有 PEG 的基团或与位置 4 或位置 5 结合的羟基 C1-5 烷氧基,R2 是位于位置 6 的氨基,R3 和 R4 各自独立地为氢原子、烷基、芳基、芳烷基或芳氧基。